Radiobiological characterization of two human chemotherapy-resistant intermediate grade non-Hodgkin's lymphoma cell lines.

A Aref, R Mohammad, M Yudelev, R Choudhuri, A Strowbridge, C Orton, A al-Katib
{"title":"Radiobiological characterization of two human chemotherapy-resistant intermediate grade non-Hodgkin's lymphoma cell lines.","authors":"A Aref,&nbsp;R Mohammad,&nbsp;M Yudelev,&nbsp;R Choudhuri,&nbsp;A Strowbridge,&nbsp;C Orton,&nbsp;A al-Katib","doi":"10.1002/(SICI)1520-6823(1999)7:3<158::AID-ROI4>3.0.CO;2-B","DOIUrl":null,"url":null,"abstract":"<p><p>Intermediate grade non-Hodgkin's lymphoma (IGNHL) is generally considered a radiosensitive tumor that can be controlled with moderate radiation doses. Cell-survival curves of cell lines derived from IGNHL have been typically described to exhibit small or no shoulder, implying inability to accumulate or repair sublethal radiation damage. We characterize in this report the clonogenic radiation survival curves of two human IGNHL cell lines, WSU-DLCL2 and SK-DHL2B, established from patients who expired after having exhibited chemotherapy resistance of their tumors. The cells were irradiated with 60Co radiation at a dose rate of 85-100 cGy/min and cell survival data were analyzed according to the linear quadratic model. The alpha/beta values for WSU-DLCL2 and SK-DHL2B cells are 2 and 8.6, respectively. The corresponding SF2 are 0.42 and 0.35, respectively. Both cell lines are able to repair radiation-induced sublethal damage. These data indicate that these cells are only moderately radiosensitive.</p>","PeriodicalId":20894,"journal":{"name":"Radiation oncology investigations","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1520-6823(1999)7:3<158::AID-ROI4>3.0.CO;2-B","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiation oncology investigations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/(SICI)1520-6823(1999)7:3<158::AID-ROI4>3.0.CO;2-B","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Intermediate grade non-Hodgkin's lymphoma (IGNHL) is generally considered a radiosensitive tumor that can be controlled with moderate radiation doses. Cell-survival curves of cell lines derived from IGNHL have been typically described to exhibit small or no shoulder, implying inability to accumulate or repair sublethal radiation damage. We characterize in this report the clonogenic radiation survival curves of two human IGNHL cell lines, WSU-DLCL2 and SK-DHL2B, established from patients who expired after having exhibited chemotherapy resistance of their tumors. The cells were irradiated with 60Co radiation at a dose rate of 85-100 cGy/min and cell survival data were analyzed according to the linear quadratic model. The alpha/beta values for WSU-DLCL2 and SK-DHL2B cells are 2 and 8.6, respectively. The corresponding SF2 are 0.42 and 0.35, respectively. Both cell lines are able to repair radiation-induced sublethal damage. These data indicate that these cells are only moderately radiosensitive.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
两种人类化疗耐药中级非霍奇金淋巴瘤细胞系的放射生物学特性。
中度非霍奇金淋巴瘤(IGNHL)通常被认为是一种放射敏感的肿瘤,可以用中等剂量的辐射来控制。来自IGNHL的细胞系的细胞存活曲线通常表现为小肩或无肩,这意味着无法积累或修复亚致死辐射损伤。我们在本报告中描述了两种人类IGNHL细胞系WSU-DLCL2和SK-DHL2B的克隆源性辐射生存曲线,这些细胞系建立于肿瘤出现化疗耐药后死亡的患者。用剂量率为85 ~ 100 cGy/min的60Co辐射照射细胞,按线性二次模型分析细胞存活数据。WSU-DLCL2和SK-DHL2B细胞的α / β值分别为2和8.6。相应的SF2分别为0.42和0.35。这两种细胞系都能修复辐射引起的亚致死损伤。这些数据表明,这些细胞只有中等程度的辐射敏感性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Molecular and anatomic considerations in the pathogenesis of breast cancer. Telomeric length in individuals and cell lines with altered p53 status. Effect of combined adoptive immunotherapy and radiotherapy on tumor growth. PSA kinetics following I-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1